Hepatitis B vaccination at three months of age: A successful strategy?

Vaccine

Volumn 31, Issue 13, 2013, Pages 1696-1700

  Chiara, Federica ^a   Bartolucci, Giovanni Battista ^a   Mongillo, Michele ^a   Ferretto, Luca ^a   Nicolli, Annamaria ^a   Trevisan, Andrea ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Anti HBs; Booster vaccination; Hepatitis B; Persistence of antibodies; Vaccination

Indexed keywords

RECOMBINANT HEPATITIS B VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN;

ADULT; AGE SPECIFIC CARE; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGICAL MEMORY; ITALY; LIFESTYLE; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INFANT; ITALY; MALE; VACCINATION; YOUNG ADULT;

EID: 84875264733     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.01.046     Document Type: Article

References (27)

1. Boxall E.H., Sira J.A., El-Shuhkri N., Kelly D.A. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis 2004, 190:1264-1269.
2. Floreani A., Baldo V., Cristofoletti M., Renzulli G., Valeri A., Zanetti C., et al. Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers. Vaccine 2004, 22:607-610.
3. Hadler S.C., Francis D.P., Maynard J.E., Thompson S.E., Judson F.N., Echenberg D.F., et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986, 315:209-214.
4. McMahon B.J., Bruden D.L., Petersen K.M., Bulkow L.R., Parkinson A.J., Nainan O., et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 2005, 142:333-341.
5. Gabbuti A., Romanò L., Blanc P., Meacci F., Amendola A., Mele A., et al. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine 2007, 25:3129-3132.
6. Poovorawan Y., Chongsrisawat V., Theamboonlers A., Bock H.L., Leyssen M., Jacquet J.M. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine 2010, 28:730-736.
7. European Consensus Group on Hepatitis B Immunity Are booster immunisations needed for lifelong hepatitis B immunity?. Lancet 2000, 355:561-565.
8. Rantala M., van de Laar M.J. Surveillance and epidemiology of hepatitis B and C in Europe - a review. Euro Surveill 2008, 13(21). pii:18880.
9. Saffar M.J., Rezai M.S. Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth. Indian Pediatr 2004, 41:1232-1237.
10. Pollard A.J., Perrett K.P., Beverley P.C. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat Rev Immunol 2009, 9:213-220.
11. Delage G., Remy-Prince S., Montplaisir S. Combined active-passive immunization against the hepatitis B virus: five-year follow-up of children born to hepatitis B surface antigen-positive mothers. Pediatr Infect Dis J 1993, 12:126-130.
12. Williams I.T., Goldstein S.T., Tufa J., Tauillii S., Margolis H.S., Mahoney F.J. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J 2003, 22:157-163.
13. Bialek S.R., Bower W.A., Novak R., Helgenberger L., Auerbach S.B., Williams I.T., et al. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J 2008, 27:881-885.
14. Bauer T., Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 2006, 24:572-577.
15. West D.J., Calandra G.B. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 1996, 14:1019-1027.
16. Zanetti A.R., Mariano A., Romanò L., D'Amelio R., Chironna M., Coppola R.C., et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005, 366:1379-1384.
17. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC) Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011, 60(RR-7):1-45.
18. Lau Y.L. Hepatitis B vaccination in preterm infants. Pediatr Infect Dis J 1994, 13:243.
19. Alimonos K., Nafziger A.N., Murray J., Bertino J.S. Prediction of response to hepatitis B vaccine in health care workers: whose titers of antibody to hepatitis B surface antigen should be determined after a three-dose series, and what are the implications in terms of cost-effectiveness. Clin Infect Dis 1998, 26:566-571.
20. Marinho R.T., Moura M.C., Pedro M., Ramalho F.J., Velosa J.F. Hepatitis B vaccination in hospital personnel and medical students. J Clin Gastroenterol 1999, 28:317-322.
21. Lu J.J., Cheng C.C., Chou S.M., Hor C.B., Yang Y.C., Wang H.L. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan. Vaccine 2009, 27:6613-6618.
22. Wu J.S., Hwang L.Y., Goodman K.J., Beasley R.P. Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 1999, 179:1319-1325.
23. Averhoff F., Mahoney F., Coleman P., Schatz G., Hurwitz E., Margolis H. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998, 15:1-8.
24. Keating G.M., Noble S. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B. Drugs 2003, 63:1021-1051.
25. Wainwright R.B., Bulkow L.R., Parkinson A.J., Zanis C., McMahon B.J. Protection provided by hepatitis B vaccine in a Yupik Eskimo population-results of a 10-year study. J Infect Dis 1997, 175:674-677.
26. Burgess M.A., McIntosh E.D., Allars H.M., Kenrick K.G. Hepatitis B in urban Australian schoolchildren. No evidence of horizontal transmission between high-risk and low-risk groups. Med J Aust 1993, 159:315-319.
27. Stroffolini T., Mele A., Tosti M.E., Gallo G., Balocchini E., Ragni P., et al. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol 2000, 33:980-985.